Holen Sie sich die Stockscreener-App
40.79
3.02%
-1.27
Handel nachbörslich:
40.63
-0.16
-0.39%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$42.06
Offen:
$41.8
24-Stunden-Volumen:
1.11M
Relative Volume:
1.10
Marktkapitalisierung:
$2.17B
Einnahmen:
$238.11M
Nettoeinkommen (Verlust:
$-31.45M
KGV:
-64.40
EPS:
-0.6334
Netto-Cashflow:
$7.66M
1W Leistung:
-4.32%
1M Leistung:
+27.63%
6M Leistung:
+66.76%
1J Leistung:
+258.91%
1-Tages-Spanne:
$40.06
$42.20
1-Wochen-Bereich:
$40.06
$44.45
52-Wochen-Spanne:
$9.215
$45.83
Axogen Inc Stock (AXGN) Company Profile
Firmenname
Axogen Inc
Sektor
Branche
Telefon
(386) 462-6817
Adresse
13631 PROGRESS BLVD., ALACHUA, FL
Compare AXGN vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
AXGN
Axogen Inc
|
40.79 | 2.24B | 238.11M | -31.45M | 7.66M | -0.6334 |
ABT
Abbott Laboratories
|
82.56 | 146.87B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
282.58 | 109.33B | 25.27B | 3.34B | 4.57B | 8.6358 |
MDT
Medtronic Plc
|
74.54 | 97.77B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
53.37 | 80.16B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
77.17 | 46.04B | 6.30B | 1.07B | 1.09B | 1.8406 |
Axogen Inc Stock (AXGN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-02-19 | Eingeleitet | Wells Fargo | Overweight |
| 2025-12-01 | Eingeleitet | Mizuho | Outperform |
| 2025-03-17 | Eingeleitet | Lake Street | Buy |
| 2024-07-01 | Eingeleitet | Raymond James | Outperform |
| 2022-11-11 | Fortgesetzt | Jefferies | Buy |
| 2022-05-09 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2022-03-11 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2020-10-23 | Eingeleitet | Guggenheim | Buy |
| 2020-06-16 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2020-05-07 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2020-04-02 | Herabstufung | BTIG Research | Buy → Neutral |
| 2019-08-07 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2019-07-12 | Eingeleitet | Canaccord Genuity | Buy |
| 2018-03-02 | Bestätigt | Lake Street | Buy |
| 2018-01-05 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2017-11-30 | Eingeleitet | Jefferies | Buy |
| 2017-11-21 | Bestätigt | Lake Street | Buy |
| 2017-07-31 | Eingeleitet | Leerink Partners | Outperform |
| 2017-06-30 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2017-03-06 | Eingeleitet | ROTH Capital | Buy |
| 2016-11-22 | Hochstufung | Lake Street | Hold → Buy |
| 2016-11-07 | Bestätigt | Wedbush | Outperform |
| 2016-11-03 | Herabstufung | Lake Street | Buy → Hold |
| 2016-08-04 | Bestätigt | Wedbush | Outperform |
| 2014-05-14 | Eingeleitet | Dawson James | Buy |
| 2013-10-31 | Bestätigt | Ladenburg Thalmann | Buy |
Alle ansehen
Axogen Inc Aktie (AXGN) Neueste Nachrichten
Technical Reactions to AXGN Trends in Macro Strategies - Stock Traders Daily
Insider Sell Alert: Jens Kemp Sells 4,000 Shares of Axogen Inc (AXGN) - GuruFocus
Axogen CMO Jens Kemp sells $173,761 in company stock By Investing.com - Investing.com Nigeria
Axogen CFO Lindsey Hartley sells $45,897 in AXGN stock By Investing.com - Investing.com Nigeria
Axogen CFO Lindsey Hartley sells $45,897 in AXGN stock - Investing.com UK
[144] Axogen, Inc. SEC Filing - Stock Titan
Axogen Director Sold Shares Worth Over $720K - TradingView
Axogen (AXGN) director exercises options and sells 11,050 common shares - Stock Titan
[Form 4] Axogen, Inc. Insider Trading Activity - Stock Titan
Axogen (AXGN) CMO sells 4,000 shares around $43 per share - Stock Titan
Axogen (NASDAQ: AXGN) CFO nets shares after option exercises and sales - Stock Titan
Axogen (AXGN) Sales VP sells 3,878 shares, retains 92,416 - Stock Titan
Axogen (NASDAQ: AXGN) VP Quackenbush discloses initial equity holdings - Stock Titan
AxoGen, Inc. (AXGN) Stock Analysis: 17% Upside Potential Amid Robust Revenue Growth - DirectorsTalk Interviews
AXGN (NASDAQ) Form 144 lists 3,878 shares via Morgan Stanley broker - Stock Titan
First Light, Mathew Arens report 3.62M Axogen holdings (AXGN) - Stock Titan
How many employees work at AxoGen? - Revelio Labs
Number of shareholders of Axogen, Inc. – NASDAQ:AXGN - TradingView
Axogen outlines at least $270M 2026 revenue on at least 20% growth amid Avance biologic channel transition - MSN
Canaccord Genuity Sticks to Its Buy Rating for AxoGen (AXGN) - The Globe and Mail
Axogen (AXGN) Is Up 10.3% After Raising 2026 Revenue Outlook Despite Wider Q1 Loss – Has The Bull Case Changed? - simplywall.st
Axogen (AXGN) Q1 2025 Earnings Transcript - AOL.com
AxoGen (NASDAQ:AXGN) Cut to "Hold" at Wall Street Zen - MarketBeat
Axogen, Inc. (NASDAQ:AXGN) Just Reported And Analysts Have Been Lifting Their Price Targets - 富途牛牛
Axogen, Inc. (NASDAQ:AXGN) Analysts Are Pretty Bullish On The Stock After Recent Results - Yahoo Finance
Axogen (AXGN) Q1 2026 Deep Dive: $0.07 EPS, Revenue Up 27% - AlphaStreet
Nerve Repair And Regenerative Market Set to Boom Rapidly, - openPR.com
Axogen, Inc. to Participate in the 2026 Bank of America Global Healthcare Conference - The Manila Times
Axogen, Inc. (NASDAQ:AXGN) Released Earnings Last Week And Analysts Lifted Their Price Target To US$50.78 - simplywall.st
AxoGen Reports Third Quarter 2025 Financial Results and Growth - HarianBasis.co
AXGN Maintained by Canaccord Genuity -- Price Target Raised to $50 - GuruFocus
Vanguard reports 2.66M Axogen stake (NASDAQ: AXGN) - Stock Titan
[ARS] Axogen, Inc. SEC Filing - Stock Titan
FDA win and 20% growth frame Axogen (NASDAQ: AXGN) 2026 pay vote - Stock Titan
AXGN Maintained by Citizens -- Price Target Raised to $50.00 - GuruFocus
AxoGen (NASDAQ:AXGN) Releases Quarterly Earnings Results, Misses Estimates By $0.04 EPS - MarketBeat
AXGN Maintained by Wells Fargo -- Price Target Raised to $38.00 - GuruFocus
AxoGen (NASDAQ:AXGN) Price Target Raised to $48.00 at Wells Fargo & Company - MarketBeat
Axogen Q1 2026 revenue up 26.6% to USD 61.5M - Medical Buyer
Citizens raises AxoGen stock price target to $50 on strong sales - Investing.com Australia
AXGN Maintained by HC Wainwright & Co. -- Price Target Raised to $50 - GuruFocus
H.C. Wainwright raises AxoGen stock price target to $50 on revenue beat - Investing.com Nigeria
H.C. Wainwright raises AxoGen stock price target to $50 on revenue beat By Investing.com - Investing.com South Africa
Mizuho raises AxoGen stock price target to $55 on strong growth By Investing.com - Investing.com South Africa
AxoGen Delivers Strong Q1 Growth and Raises 2026 Outlook - The Globe and Mail
Mizuho raises AxoGen stock price target to $55 on strong growth - Investing.com Australia
AxoGen (NASDAQ:AXGN) Rating Lowered to Strong Sell at Zacks Research - MarketBeat
Finanzdaten der Axogen Inc-Aktie (AXGN)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.34%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):